Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash Institute of Pharmaceutical ...

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...

There is a process to a patient being diagnosed with a rare condition and then collaborating with their physician, if they are fortunate enough to have that opporunity. One recent qualitative study ...

A case report demonstrating sequential neurorepair, lipid repletion, microbiome stabilization, and mitochondrial support in ...

As L.C. Clark, the former chief of the district’s campus police, put it: The children of Wilkinson County haven’t yet had the ...

Researchers discover a gut-brain-heart axis where the bacterial metabolite IAA regulates hypocretin neurons to control heart stiffness and blood pressure.

Frontiers in Oncology publication positions metabo-oncology as a differentiated platform for pharma and a novel, ...

U.S. District Judge Michael Farbiarz prohibited ICE from moving an immigrant, Baljinder Kumar, out of New Jersey while he challenged his unlawful detention. Five days later, Immigration and Customs ...